
|Articles|August 1, 2001
- Pharmaceutical Technology-08-01-2001
- Volume 2001 Supplement
- Issue 2
Successfully Outsourcing Formulation DevelopmentConsiderations for Emerging Biopharmaceutical Companies
Author(s)Shabbir T. Anik, PhD, Colin M. Minchom, PhD
Successfully taking a new chemical entity from proof-of-concept to commercialization requires the biopharmaceutical company to carefully evaluate a contract services provider's formulation department and ability to become a fully integrated supplier.
Advertisement
Articles in this issue
almost 25 years ago
Creating a Successful Partnership with a Contract Manufactureralmost 25 years ago
Outsourcing Outlookalmost 25 years ago
Creative Solutions in Client-CRO Relationshipsalmost 25 years ago
Third-Party Technology Transferalmost 25 years ago
The Squeeze in Contract Manufacturingalmost 25 years ago
Stakes Rise for Blown Batchesalmost 25 years ago
Partnerships in Drug DiscoveryAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
PharmTech Weekly Roundup—July 17, 2026
5




